Palatability of a Novel Oral Formulation of Prednsione
Phase of Trial: Phase I
Latest Information Update: 13 Dec 2018
Price : $35 *
At a glance
- Drugs Prednisone (Primary) ; Prednisone
- Indications Asthma; Atopic dermatitis; Bronchitis; Cancer; Eczema; Nephrotic syndrome
- Focus First in man; Proof of concept; Therapeutic Use
- 18 Mar 2017 Results presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 17 Feb 2016 Status changed from not yet recruiting to completed as per ClinicalTrials.gov record.
- 06 Jan 2015 Planned End Date changed from 1 Jan 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record.